You Searched For "glenmark life science stocks" and got 20 results
Sort By:
Glenmark to divest 75% stake in Glenmark Life Sciences to Nirma; stock slips
The Glenmark Pharmaceuticals stock was almost down 5% in Friday morning trade after the pharma maj…
Satya Nadella's career rise, from computer science student to turning Microsoft into a $3 trillion titan as CEO
Satya Nadella has been running Microsoft for a decade. Here's how the company became a $3 trillion …
Sarah Jackson,Polly Thompson,…
Watch out for the semiconductor supercycle before you start buying stocks like Nvidia
Nvidia is now one of the world's most valuable companies, but experts told Business Insider that it…
Kwan Wei Kevin Tan
Glenmark Life Sciences IPO is nearly as big as its debt but the funds will go into expanding its plants
Glenmark Pharmaceuticals’ subsidiary Glenmark Life Sciences is all prepped up to launch its ₹1,060 …
Market Morning: Sensex, Nifty off to a muted start, Sun Pharma, KEI in spotlight
Nifty50 and Sensex started slow with Nifty50 at 23,661.15 points. Sun Pharma stocks rose by 0.36% a…
Glenmark Life Sciences IPO: Shares list at 4% premium on exchanges
Shares of Glenmark Life Sciences made a decent listing on National Stock Exchange (NSE) and BSE at …
Glenmark Life Sciences IPO: How to check allotment status, listing date and more
The public issue of Glenmark Pharmaceuticals’ subsidiary Glenmark Life Sciences is likely to announ…
Glenmark Life Sciences IPO gets subscribed 45.08 times on the last day of issue
The public issue of Glenmark Pharmaceuticals’ subsidiary Glenmark Life Sciences saw strong demand f…
One may subscribe to Glenmark Life Sciences IPO because of clean regulatory history, strong promoter backing and good track record, say analysts
The IPO is likely to open on July 27 and close on July 29. Shares of the company are expected to…
Glenmark Pharmaceuticals subsidiary Glenmark Life Sciences to raise ₹1,060 crore through IPO
While the year 2021 has already seen 35 initial public offerings (IPO) on exchanges, there are many…
I quit teaching and broke into tech with a coding boot camp. It's given me the life I dreamed about.
Xavier Carrillo wanted a better work-life balance and a higher income after teaching through the pa…
Jane Zhang
It's shaping up to be a tough summer for the stock market, but Nvidia could help salvage things
The summer months have historically been tough on stocks.
Dan DeFrancesco
Peter Thiel-backed psychedelics company plans to raise $100 million in an IPO
Atai Life Sciences, a company that aims to use psychedelic compounds for therapeutic uses, is plann…
Emily Graffeo
Rakesh Jhunjhunwala-backed Concord Biotech files for an IPO
Ahmedabad-based Concord Biotech has filed for an IPO, giving its promoter Quadria Capital a way to …
Meet Blackstone's life-science dealmakers
These are Insider's biggest healthcare stories for August 31.
Lydia Ramsey Pflanzer
Mankind Pharma, PNB among stocks to become largecap from midcap; mutibagger Rail Vikas Nigam to turn midcap from smallcap
The Association of Mutual Funds in India (AMFI) releases reclassification of largecap, midcap an…
A British biotech company could be benefiting from ticker confusion with Tesla
The number of Robinhood users holding Tiziana Life Sciences' receipts, which trade with the ticker …
Ben Winck
Your VO2 max is like a '401(k) for longevity' — here's how to invest in it for better heart health and a longer life
VO2 max is a marker of endurance, usually measured with a stress test; the higher it is, the better…
Gabby Landsverk
Big Bull Rakesh Jhunjhunwala added nearly $40 million to net worth in the last four months— these are the stocks he bet on
Moreover, Jhunjhunwala has become one of the few billionaires in the country to have increased t…